Crossmark

Reducing rates of chronic breast cancer–related lymphedema with screening and early intervention: an update of recent data

Published Online: 2022-08-10

Published Print: 2024-04

Authors

Whitworth, Pat

Vicini, Frank

Valente, Stephanie A.

Brownson, Kirstyn

DuPree, Beth

Kohli, Manpreet

Lawson, Laura

Shah, Chirag
License Information

Text and Data Mining valid from 2022-08-10

Version of Record valid from 2022-08-10
More Information

Article History

Received: 9 June 2022

Accepted: 23 July 2022

First Online: 10 August 2022

Declarations

:

: As this is a review article, IRB review was not obtained.

: This is a review article.

: Pat Whitworth is a partner of TME LLC and a consultant for Impedimed. Chirag Shah is a consultant for ImpediMed, PreludeDX, Videra Surgical, and Evicore and has received grants from Varian Medical Systems, VisionRT, and PreludeDx. Frank Vicini is a consultant for ImpediMed and PreludeDX. Stephanie Valente is a consultant and speaker for ImpediMed, AxoGen, Pacira, and Merit Medical. Kirstyn Brownson, Beth Dupree, Manpreet Kohli, and Laura Lawson have no relevant financial or non-financial interests to disclose.

Document is current